2025 H2 -tulosraportti
89 päivää sitten
‧38 min
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 115 | - | - | ||
| 878 | - | - | ||
| 2 623 | - | - | ||
| 127 | - | - | ||
| 4 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·2 t sittenI think that the large investors are very satisfied with keeping the price at this level. There were quite a few buyers who paid over kr 5 per share a short while ago. I expect great demand for the share when the factory is completed. If new users appear, a double-digit price is conceivable.
·6 t sittenKi : Yes, there is a direct and very important historical connection between thorium, key figures in the Norwegian thorium industry, and the Halden Reactor. Although the Halden Reactor (which was operated by IFE – Institute for Energy Technology) was permanently shut down in 2018, for many years it was a central, global testing arena for thorium as future nuclear fuel. Here are the most important connections: 1. Thor Energy and the historical thorium experiments The most concrete connection is found in the Norwegian company Thor Energy (which originally emerged from the Scatec system and Alf Bjørseth). World's first experiment (2013–2018): In April 2013, Thor Energy, in collaboration with IFE, started a historical test program in the Halden Reactor. For the very first time in the world, commercially developed thorium fuel (mixed with plutonium/uranium, so-called ThMOX) was burned in a conventional, operational test reactor. What they tested: The purpose was to prove that thorium fuel behaved stably, maintained lower temperatures than pure uranium fuel, and could thus be phased into existing nuclear power plants worldwide to create safer and more long-lasting fuel with less hazardous waste. 2. Key people behind the scenes Several of the key players who today run companies within the thorium and biotechnology sphere in Norway have either started their careers or collaborated closely with the professional community in Halden: Øystein Asphjell: As CEO of Thor Energy, he was the one who led and spearheaded the entire large thorium test program inside the Halden Reactor until its closure. The research environment around nuclear medicine: The expertise built up around reactor operation and radiation safety in Halden (and at Kjeller) has been absolutely fundamental for the emergence of the Norwegian cluster in the radiopharmaceutical industry. Several researchers and experts in nuclear chemistry and physics have moved from IFE's reactor environments to companies working with the medical use of alpha emitters based on thorium (such as researchers associated with Thor Medical). 3. What happened afterwards? When the Halden Reactor was decided to be shut down in 2018 (due to technical challenges and economics), the physical fuel tests in Norway also ceased. However, the testing provided valuable data that Thor Energy and international partners have carried forward into simulation programs and further development of fuel patents. In other words, the unique testing environment in Halden was the very engine that proved that the "Norwegian" thorium fuel actually worked in practice.
·2 t sittenYou are absolutely right that the Halden reactor (HBWR) was never intended as a full thorium power reactor, but as a test platform. Thor Energy nevertheless did groundbreaking work there from 2013–2018 with Th MOX and Th Add fuel (thorium mixed with plutonium/uranium). The tests showed, among other things, lower operating temperatures and good stability in conventional light water reactors – data that are still valuable today. The reactor was shut down in 2018 due to economic/technical reasons, but the expertise from the IFE environment and Thor Energy lives on in both energy and medical thorium use (as you point out with people like Øystein Asphjell and the transition to radiopharma). Further evidence that thorium technology is still actively being developed and tested today, especially in molten salt reactors (MSR) and modern fuel: China and TMSR LF1 (Thorium Molten Salt Reactor) The world's only operational thorium-fueled MSR right now. First criticality October 2023. Full power June 2024. October 2024: First time in the world thorium was added and the reactor operated with thorium fuel without shutting down. November 2025: First successful thorium → U-233 conversion/breeding in an operational MSR, with real experimental data. This confirms technical feasibility for the thorium/uranium cycle in molten salt. Next step: 100 MWt demonstration around 2035. (Sources: Shanghai Institute of Applied Physics / Chinese Academy of Sciences, World Nuclear News 4. Nov 2025) USA and Clean Core Thorium Energy (ANEEL fuel) Patented thorium+HALEU fuel (high assay low-enriched uranium) that can be used in existing PHWR/CANDU reactors. Irradiation test in Idaho National Lab’s Advanced Test Reactor (ATR) completed May 2026. Achieved over 60 GWd/MTU burnup, over 8 times typical for conventional fuel in such reactors. Lower waste, higher utilization and better safety. The tests now include post irradiation analysis for licensing. (Sources: World Nuclear News 7. May 2026, INL and Clean Core official updates) These examples show that thorium is not just «historical» – it is being tested and validated in modern, operating reactors and fuel right now. Halden provided valuable data for solid fuel, while the MSR concept (which China leads) utilizes thorium's advantages even better: online refuelling, low waste and high temperature for industrial heat/hydrogen. For Thor Medical, there is of course another use: pure chemical extraction of alpha particle emitters from natural Th-232 (no reactor necessary). The AlphaOne facility at Herøya is mechanically completed April 2026 and is scheduled for commercial production Q3 2026 just in time to meet the growing demand in Targeted Alpha Therapy. Thorium thus has several lives: energy and medicine. Very interesting to follow both! (Sources linked above, all public and recent.)- ·3 päivää sittenHi again, Thor Medical is still a pure medical company that is building the AlphaOne factory at Herøya for the production of thorium-228 (Th-228) for Targeted Alpha Therapy (TAT), a promising new cancer treatment. Production start is planned for Q3 2026, and they already have a solid order book of around 850 mill. NOK. What is worth noting right now is that the same Norwegian thorium raw material (Th-232 from Fensfeltet via Rare Earths Norway) is also in play on the energy side: According to a recent article, Copenhagen Atomics and the Norwegian company Ocean-Power have entered into an MoU to explore the development of thorium-based molten salt reactors (MSR) in Norway already in the 2030s. The goal is to produce green electricity and heat with compact, factory-built reactors. Article: https://energiwatch.no/nyheter/fornybar/article19321137.ece Rare Earths Norway has previously entered into LoI with both Thor Medical (medicine) and Copenhagen Atomics (energy). This means that the same thorium source can be used in two completely different value chains. This is not TRMED's strategy as of today. The company is 100% focused on medicine today. But it shows that Norway could potentially get a thorium ecosystem that covers both medicine and future nuclear power. Interesting to follow for those interested in thorium technology in general. Have a good weekend🫡
- ·22.5. · MuokattuBrief summary from Grok AI: TRMED's thorium supply chain is not just medicine (TAT cancer treatment via AlphaOne Q3 2026) — it is also a strategic bridge to future thorium molten salt reactors (MSR) (via the Rare Earths Norway agreements with Copenhagen Atomics, the IMSR ecosystem, etc.). The dual effect (medical isotopes today + raw material for clean energy tomorrow) is exactly the type of real thorium infrastructure that can accelerate MSR rollout… which, as you've said all along, is extremely beneficial for AI — because it provides the massive, stable power hyperscalers need for their data centers.·2 t sittenThanks...Excellent further elaboration... nuclear physics is not for "everyone"... can seem simple... but is extremely complicated when one goes into the details regarding Thorium as reactor "fuel", the value chain is necessary to succeed..... otherwise completely agree regarding Thor Medical.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H2 -tulosraportti
89 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 t sittenI think that the large investors are very satisfied with keeping the price at this level. There were quite a few buyers who paid over kr 5 per share a short while ago. I expect great demand for the share when the factory is completed. If new users appear, a double-digit price is conceivable.
- ·6 t sittenKi : Yes, there is a direct and very important historical connection between thorium, key figures in the Norwegian thorium industry, and the Halden Reactor. Although the Halden Reactor (which was operated by IFE – Institute for Energy Technology) was permanently shut down in 2018, for many years it was a central, global testing arena for thorium as future nuclear fuel. Here are the most important connections: 1. Thor Energy and the historical thorium experiments The most concrete connection is found in the Norwegian company Thor Energy (which originally emerged from the Scatec system and Alf Bjørseth). World's first experiment (2013–2018): In April 2013, Thor Energy, in collaboration with IFE, started a historical test program in the Halden Reactor. For the very first time in the world, commercially developed thorium fuel (mixed with plutonium/uranium, so-called ThMOX) was burned in a conventional, operational test reactor. What they tested: The purpose was to prove that thorium fuel behaved stably, maintained lower temperatures than pure uranium fuel, and could thus be phased into existing nuclear power plants worldwide to create safer and more long-lasting fuel with less hazardous waste. 2. Key people behind the scenes Several of the key players who today run companies within the thorium and biotechnology sphere in Norway have either started their careers or collaborated closely with the professional community in Halden: Øystein Asphjell: As CEO of Thor Energy, he was the one who led and spearheaded the entire large thorium test program inside the Halden Reactor until its closure. The research environment around nuclear medicine: The expertise built up around reactor operation and radiation safety in Halden (and at Kjeller) has been absolutely fundamental for the emergence of the Norwegian cluster in the radiopharmaceutical industry. Several researchers and experts in nuclear chemistry and physics have moved from IFE's reactor environments to companies working with the medical use of alpha emitters based on thorium (such as researchers associated with Thor Medical). 3. What happened afterwards? When the Halden Reactor was decided to be shut down in 2018 (due to technical challenges and economics), the physical fuel tests in Norway also ceased. However, the testing provided valuable data that Thor Energy and international partners have carried forward into simulation programs and further development of fuel patents. In other words, the unique testing environment in Halden was the very engine that proved that the "Norwegian" thorium fuel actually worked in practice.·2 t sittenYou are absolutely right that the Halden reactor (HBWR) was never intended as a full thorium power reactor, but as a test platform. Thor Energy nevertheless did groundbreaking work there from 2013–2018 with Th MOX and Th Add fuel (thorium mixed with plutonium/uranium). The tests showed, among other things, lower operating temperatures and good stability in conventional light water reactors – data that are still valuable today. The reactor was shut down in 2018 due to economic/technical reasons, but the expertise from the IFE environment and Thor Energy lives on in both energy and medical thorium use (as you point out with people like Øystein Asphjell and the transition to radiopharma). Further evidence that thorium technology is still actively being developed and tested today, especially in molten salt reactors (MSR) and modern fuel: China and TMSR LF1 (Thorium Molten Salt Reactor) The world's only operational thorium-fueled MSR right now. First criticality October 2023. Full power June 2024. October 2024: First time in the world thorium was added and the reactor operated with thorium fuel without shutting down. November 2025: First successful thorium → U-233 conversion/breeding in an operational MSR, with real experimental data. This confirms technical feasibility for the thorium/uranium cycle in molten salt. Next step: 100 MWt demonstration around 2035. (Sources: Shanghai Institute of Applied Physics / Chinese Academy of Sciences, World Nuclear News 4. Nov 2025) USA and Clean Core Thorium Energy (ANEEL fuel) Patented thorium+HALEU fuel (high assay low-enriched uranium) that can be used in existing PHWR/CANDU reactors. Irradiation test in Idaho National Lab’s Advanced Test Reactor (ATR) completed May 2026. Achieved over 60 GWd/MTU burnup, over 8 times typical for conventional fuel in such reactors. Lower waste, higher utilization and better safety. The tests now include post irradiation analysis for licensing. (Sources: World Nuclear News 7. May 2026, INL and Clean Core official updates) These examples show that thorium is not just «historical» – it is being tested and validated in modern, operating reactors and fuel right now. Halden provided valuable data for solid fuel, while the MSR concept (which China leads) utilizes thorium's advantages even better: online refuelling, low waste and high temperature for industrial heat/hydrogen. For Thor Medical, there is of course another use: pure chemical extraction of alpha particle emitters from natural Th-232 (no reactor necessary). The AlphaOne facility at Herøya is mechanically completed April 2026 and is scheduled for commercial production Q3 2026 just in time to meet the growing demand in Targeted Alpha Therapy. Thorium thus has several lives: energy and medicine. Very interesting to follow both! (Sources linked above, all public and recent.)
- ·3 päivää sittenHi again, Thor Medical is still a pure medical company that is building the AlphaOne factory at Herøya for the production of thorium-228 (Th-228) for Targeted Alpha Therapy (TAT), a promising new cancer treatment. Production start is planned for Q3 2026, and they already have a solid order book of around 850 mill. NOK. What is worth noting right now is that the same Norwegian thorium raw material (Th-232 from Fensfeltet via Rare Earths Norway) is also in play on the energy side: According to a recent article, Copenhagen Atomics and the Norwegian company Ocean-Power have entered into an MoU to explore the development of thorium-based molten salt reactors (MSR) in Norway already in the 2030s. The goal is to produce green electricity and heat with compact, factory-built reactors. Article: https://energiwatch.no/nyheter/fornybar/article19321137.ece Rare Earths Norway has previously entered into LoI with both Thor Medical (medicine) and Copenhagen Atomics (energy). This means that the same thorium source can be used in two completely different value chains. This is not TRMED's strategy as of today. The company is 100% focused on medicine today. But it shows that Norway could potentially get a thorium ecosystem that covers both medicine and future nuclear power. Interesting to follow for those interested in thorium technology in general. Have a good weekend🫡
- ·22.5. · MuokattuBrief summary from Grok AI: TRMED's thorium supply chain is not just medicine (TAT cancer treatment via AlphaOne Q3 2026) — it is also a strategic bridge to future thorium molten salt reactors (MSR) (via the Rare Earths Norway agreements with Copenhagen Atomics, the IMSR ecosystem, etc.). The dual effect (medical isotopes today + raw material for clean energy tomorrow) is exactly the type of real thorium infrastructure that can accelerate MSR rollout… which, as you've said all along, is extremely beneficial for AI — because it provides the massive, stable power hyperscalers need for their data centers.·2 t sittenThanks...Excellent further elaboration... nuclear physics is not for "everyone"... can seem simple... but is extremely complicated when one goes into the details regarding Thorium as reactor "fuel", the value chain is necessary to succeed..... otherwise completely agree regarding Thor Medical.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 115 | - | - | ||
| 878 | - | - | ||
| 2 623 | - | - | ||
| 127 | - | - | ||
| 4 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
2025 H2 -tulosraportti
89 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 t sittenI think that the large investors are very satisfied with keeping the price at this level. There were quite a few buyers who paid over kr 5 per share a short while ago. I expect great demand for the share when the factory is completed. If new users appear, a double-digit price is conceivable.
- ·6 t sittenKi : Yes, there is a direct and very important historical connection between thorium, key figures in the Norwegian thorium industry, and the Halden Reactor. Although the Halden Reactor (which was operated by IFE – Institute for Energy Technology) was permanently shut down in 2018, for many years it was a central, global testing arena for thorium as future nuclear fuel. Here are the most important connections: 1. Thor Energy and the historical thorium experiments The most concrete connection is found in the Norwegian company Thor Energy (which originally emerged from the Scatec system and Alf Bjørseth). World's first experiment (2013–2018): In April 2013, Thor Energy, in collaboration with IFE, started a historical test program in the Halden Reactor. For the very first time in the world, commercially developed thorium fuel (mixed with plutonium/uranium, so-called ThMOX) was burned in a conventional, operational test reactor. What they tested: The purpose was to prove that thorium fuel behaved stably, maintained lower temperatures than pure uranium fuel, and could thus be phased into existing nuclear power plants worldwide to create safer and more long-lasting fuel with less hazardous waste. 2. Key people behind the scenes Several of the key players who today run companies within the thorium and biotechnology sphere in Norway have either started their careers or collaborated closely with the professional community in Halden: Øystein Asphjell: As CEO of Thor Energy, he was the one who led and spearheaded the entire large thorium test program inside the Halden Reactor until its closure. The research environment around nuclear medicine: The expertise built up around reactor operation and radiation safety in Halden (and at Kjeller) has been absolutely fundamental for the emergence of the Norwegian cluster in the radiopharmaceutical industry. Several researchers and experts in nuclear chemistry and physics have moved from IFE's reactor environments to companies working with the medical use of alpha emitters based on thorium (such as researchers associated with Thor Medical). 3. What happened afterwards? When the Halden Reactor was decided to be shut down in 2018 (due to technical challenges and economics), the physical fuel tests in Norway also ceased. However, the testing provided valuable data that Thor Energy and international partners have carried forward into simulation programs and further development of fuel patents. In other words, the unique testing environment in Halden was the very engine that proved that the "Norwegian" thorium fuel actually worked in practice.·2 t sittenYou are absolutely right that the Halden reactor (HBWR) was never intended as a full thorium power reactor, but as a test platform. Thor Energy nevertheless did groundbreaking work there from 2013–2018 with Th MOX and Th Add fuel (thorium mixed with plutonium/uranium). The tests showed, among other things, lower operating temperatures and good stability in conventional light water reactors – data that are still valuable today. The reactor was shut down in 2018 due to economic/technical reasons, but the expertise from the IFE environment and Thor Energy lives on in both energy and medical thorium use (as you point out with people like Øystein Asphjell and the transition to radiopharma). Further evidence that thorium technology is still actively being developed and tested today, especially in molten salt reactors (MSR) and modern fuel: China and TMSR LF1 (Thorium Molten Salt Reactor) The world's only operational thorium-fueled MSR right now. First criticality October 2023. Full power June 2024. October 2024: First time in the world thorium was added and the reactor operated with thorium fuel without shutting down. November 2025: First successful thorium → U-233 conversion/breeding in an operational MSR, with real experimental data. This confirms technical feasibility for the thorium/uranium cycle in molten salt. Next step: 100 MWt demonstration around 2035. (Sources: Shanghai Institute of Applied Physics / Chinese Academy of Sciences, World Nuclear News 4. Nov 2025) USA and Clean Core Thorium Energy (ANEEL fuel) Patented thorium+HALEU fuel (high assay low-enriched uranium) that can be used in existing PHWR/CANDU reactors. Irradiation test in Idaho National Lab’s Advanced Test Reactor (ATR) completed May 2026. Achieved over 60 GWd/MTU burnup, over 8 times typical for conventional fuel in such reactors. Lower waste, higher utilization and better safety. The tests now include post irradiation analysis for licensing. (Sources: World Nuclear News 7. May 2026, INL and Clean Core official updates) These examples show that thorium is not just «historical» – it is being tested and validated in modern, operating reactors and fuel right now. Halden provided valuable data for solid fuel, while the MSR concept (which China leads) utilizes thorium's advantages even better: online refuelling, low waste and high temperature for industrial heat/hydrogen. For Thor Medical, there is of course another use: pure chemical extraction of alpha particle emitters from natural Th-232 (no reactor necessary). The AlphaOne facility at Herøya is mechanically completed April 2026 and is scheduled for commercial production Q3 2026 just in time to meet the growing demand in Targeted Alpha Therapy. Thorium thus has several lives: energy and medicine. Very interesting to follow both! (Sources linked above, all public and recent.)
- ·3 päivää sittenHi again, Thor Medical is still a pure medical company that is building the AlphaOne factory at Herøya for the production of thorium-228 (Th-228) for Targeted Alpha Therapy (TAT), a promising new cancer treatment. Production start is planned for Q3 2026, and they already have a solid order book of around 850 mill. NOK. What is worth noting right now is that the same Norwegian thorium raw material (Th-232 from Fensfeltet via Rare Earths Norway) is also in play on the energy side: According to a recent article, Copenhagen Atomics and the Norwegian company Ocean-Power have entered into an MoU to explore the development of thorium-based molten salt reactors (MSR) in Norway already in the 2030s. The goal is to produce green electricity and heat with compact, factory-built reactors. Article: https://energiwatch.no/nyheter/fornybar/article19321137.ece Rare Earths Norway has previously entered into LoI with both Thor Medical (medicine) and Copenhagen Atomics (energy). This means that the same thorium source can be used in two completely different value chains. This is not TRMED's strategy as of today. The company is 100% focused on medicine today. But it shows that Norway could potentially get a thorium ecosystem that covers both medicine and future nuclear power. Interesting to follow for those interested in thorium technology in general. Have a good weekend🫡
- ·22.5. · MuokattuBrief summary from Grok AI: TRMED's thorium supply chain is not just medicine (TAT cancer treatment via AlphaOne Q3 2026) — it is also a strategic bridge to future thorium molten salt reactors (MSR) (via the Rare Earths Norway agreements with Copenhagen Atomics, the IMSR ecosystem, etc.). The dual effect (medical isotopes today + raw material for clean energy tomorrow) is exactly the type of real thorium infrastructure that can accelerate MSR rollout… which, as you've said all along, is extremely beneficial for AI — because it provides the massive, stable power hyperscalers need for their data centers.·2 t sittenThanks...Excellent further elaboration... nuclear physics is not for "everyone"... can seem simple... but is extremely complicated when one goes into the details regarding Thorium as reactor "fuel", the value chain is necessary to succeed..... otherwise completely agree regarding Thor Medical.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 115 | - | - | ||
| 878 | - | - | ||
| 2 623 | - | - | ||
| 127 | - | - | ||
| 4 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt